If this is your company, CONTACT US to activate Packbase™ software to build your portal.

    Webpackaging logo

    Aptar Pharma to host three insightful Learning Lab sessions

    Quick Contact
    • Aptar Pharma
    Aptar Pharma to host three insightful Learning Lab sessions
    Europe, France, Switzerland, France, Health, Pharmaceuticals, Shows, Associations, Media, Packaging Trade Shows, Events, Pharmapack

    Aptar Pharma, a global leader in drug delivery systems and active packaging solutions, announces that it will be a leading exhibitor at Pharmapack 2020, which will take place February 5-6 at Paris Expo, Porte de Versailles, in Paris, France.

    Located at booth A68-A70, Hall 7.2, Aptar Pharma will showcase their broad portfolio of drug delivery solutions that help improve and save lives, as well as their latest innovations across nasal, pulmonary, eye care, injectables, dermal drug delivery routes, including:

    • Aptar Pharma’s expanding range of connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes, including its soon-to-launch connected add-on device with flow sensing technology for MDIs, which has been entered into the Pharmapack 2020 Innovation Gallery and Awards
    • Innovative active packaging solutions from Aptar CSP Technologies, the active packaging specialists, who will showcase a variety of solutions including their award winning XcelerateTM Development Services, which can help expedite time-to-market for moisture- and oxygen-sensitive drugs
    • Aptar Pharma’s newly expanded services platform, with leading experts from Aptar Pharma’s analytical service companies Nanopharm, Next Breath and Gateway Analytical on hand to discuss how their value-added services can help customers accelerate and derisk their drug development journey

    Also exhibiting alongside Aptar Pharma will be Noble International, a global leader in drug delivery device trainers and patient onboarding, and the latest addition to the Aptar Pharma family. Noble specialists will be available to discuss how they can improve patient engagement and health outcomes via their robust patient onboarding strategies and adherence programs.

    Aptar Pharma will also host three insightful Learning Lab sessions on Wednesday, February 5 at Pharmapack:

    • Rethinking DPI Packaging: New Solutions to Old Challenges (13:50 – 14:20), presented by Badre Hammond, Vice-President, Commercial Operations, Aptar CSP Technologies
    • Accelerating and derisking your drug development journey (14:30–15:00), presented by Dr. Julie D. Suman, President and Founder of Next Breath, an Aptar Pharma company
    • Inhaler Devices and the Environment: Going Green Needn’t Cost the Earth (15:10–15:40), presented by Chris Baron, Director of Business Development, Rx EMEA, Aptar Pharma.

    More than 410 exhibitors and 5,500 visitors from 75 different countries are expected to attend Pharmapack 2020. Aptar Pharma looks forward to meeting with existing customers and partners from around the world, and welcomes the opportunity to make new connections in the industry to discuss how Aptar Pharma can help transform their ideas into market opportunities.

    See also

    New FDA approved combination product with Aptar Pharma's VP3 nasal spray system

    Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that its VP3 multidose device is the delivery system for Glenmark’s Ryaltris™ nasal spray, which recently received New Drug Application (NDA) approval by the U.S. Food and Drug Administration. New FDA approved combination product for seasonal allergic rhinitis symptoms with Aptar Pharma's VP3 nasal spray system

    Aptar Pharma granted exclusive license option by Pharmaxis to develop and promote high payload dry powder inhaler

    Aptar Pharma have entered into an agreement with Pharmaxis, a clinical stage drug developer, under which Aptar Pharma has the option to acquire the worldwide rights to Pharmaxis’ proprietary high payload dry powder inhaler, Orbital. As part of the agreement, Aptar Pharma will evaluate the commercial applications for the Orbital device and further develop the prototype device to meet unmet market needs. Pharmaxis retains the rights to devices containing Orbital intellectual property used to deliver inhaled mannitol.

    Noble and Aptar Pharma launch AdhereIT, a connected medical device solution for disease management adherence and onboarding patients

    Noble and Aptar Pharma are pleased to announce the launch of AdhereIT - a connected, intuitive and user-friendly onboarding solution for the growing number of patients with chronic conditions who use autoinjectors to administer their medications at home. AdhereIT is the first fully interchangeable, connected add-on solution that can work across a multitude of autoinjector platforms.

    Aptar Seeks FDA Emergency Use Authorization for Decontaminating N95 Masks with ActivShield

    AptarGroup, Inc. is seeking U.S. FDA Emergency Use Authorization (EUA) for a solution that allows easy disinfecting of N95 filtering facepiece respirators (N95 masks) using their ActivShieldTM. The N95 masks are desperately needed by healthcare personnel due to the shortage of disposable masks during the COVID-19 pandemic and this simple disinfecting process lets medical professionals reuse the masks after decontaminition.

    Aptar Pharma’s Nasal Unidose Device approved by US FDA for new nasal seizure rescue treatment

    Aptar Pharma has announced that its patented Unidose Liquid System is the device delivering a new nasal spray approved by the U.S. FDA as a rescue treatment for people with epilepsy aged six and older suffering from acute repetitive seizures. Aptar’s Unidose Liquid System is a single-use, ready-to-use one-step nasal delivery device which can deliver a formulation in an emergency situation quickly and easily.

    Aptar Pharma’s preservative-free multidose dispenser approved in the US for Allergan’s REFRESH RELIEVA PF artificial tear formulation

    Aptar Pharma has announced that its innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the delivery system for Allergan’s REFRESH RELIEVA PF, its new over-the-counter (OTC) preservative-free treatment for eye dryness in the U.S. This use reconfirms the market-leading position of Aptar Pharma’s Ophthalmic Squeeze Dispenser as the multidose delivery system for ophthalmic agents and formulations without preservatives.

    Aptar’s Nasal Unidose Device approved by US FDA

    AptarGroup, Inc, a global leader in dispensing and drug delivery solutions, has announced that its Unidose Powder System was recently approved by the U.S. Food and Drug Administration (FDA) for an intranasal, needle-free rescue treatment drug intended to treat severe hypoglycemia in people with diabetes. This marks the first FDA approval of a prescription drug using Aptar’s patented Unidose Powder System and is Aptar’s first combination of a drug delivery device with a protective active packaging container.

    Aptar acquires Nanopharm and Gateway Analytical, broadening pharma services platform to accelerate customer drug development

    AptarGroup, Inc. has announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise value of approximately $50 million. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.

    Aptar Pharma's Freepod nasal spray device with GlaxoSmithKline's Otrivin wins prestigious WPO WorldStar 2019 award

    Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that its patented Freepod nasal spray device with GlaxoSmithKline's Otrivin has received a Medical & Pharma category award at the World Packaging Organization (WPO) 2019 WorldStar Packaging Awards ceremony, which took place on May 15, 2019 in Prague. The WorldStar Awards Competition, hosted by the WPO, is considered to be one of the most prestigious international packaging awards events.

    • Company News
    • English
    • Modified 18 Dec 2019
    • Hits 842
    Sun-Rain
    APG
    Epopack